High-Level Expression of Adeno-Associated Virus (AAV) Rep78 or Rep68 Protein Is Sufficient for Infectious-Particle Formation by a Rep-Negative AAV Mutant.

Journal of Virology - United States
doi 10.1128/jvi.69.11.6880-6885.1995
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Negative Regulation of the Adeno-Associated Virus (AAV) P5 Promoter Involves Both the P5 Rep Binding Site and the Consensus ATP-binding Motif of the AAV Rep68 Protein.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1995English

Adeno-Associated Virus (AAV) Vector and AAV Empty Particles

Nihon Ika Daigaku Igakkai Zasshi
2017English

The Adeno-Associated Virus (AAV) Rep Protein Acts as Both a Repressor and an Activator to Regulate AAV Transcription During a Productive Infection.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1997English

Adeno-Associated Virus (AAV) Site-Specific Recombination Does Not Require a Rep-Dependent Origin of Replication Within the AAV Terminal Repeat

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2001English

Transmission Electron Tomography of Adeno-Associated Virus (AAV)

Microscopy and Microanalysis
Instrumentation
2010English

Evidence for Packaging of Rep-Cap Sequences Into Adeno-Associated Virus (AAV) Type 2 Capsids in the Absence of Inverted Terminal Repeats: A Model for Generation of Rep-Positive AAV Particles

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2003English

Identification and Elimination of Replication-Competent Adeno-Associated Virus (AAV) That Can Arise by Nonhomologous Recombination During AAV Vector Production.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1997English

221. The Utilization of Capsid-Optimized Adeno-Associated Virus (AAV) Vectors for Cancer Immunotherapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Developing Immunologically Inert Adeno-Associated Virus (AAV) Vectors for Gene Therapy: Possibilities and Limitations

Current Pharmaceutical Biotechnology
BiotechnologyPharmaceutical Science
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy